Certara Reports Preliminary Fourth Quarter and Full Year 2020 Results and Issues Full Year 2021 Guidance
Year-over-year 2020 revenue grew 17% to $243.5 million Raised $768.5 million in gross IPO proceeds for the Company and selling stockholders PRINCETON, N.J.—Mar. 4, 2021– Certara, Inc. （纳斯达克股票代码：CERT), a global leader in biosimulation, today reported its preliminary results for the fourth quarter and full year ended 2020 年 12 月 31 日. Highlights: Revenue was $64.6 million … Continued
